期刊文献+

高密度脂蛋白蛋白成分修饰对其抗动脉粥样硬化功能的影响 被引量:10

Effect of Protein Modification of High Density Lipoprotein on Its Antiatherogenic Function
下载PDF
导出
摘要 高密度脂蛋白(HDL)通过胆固醇逆向转运、抗氧化、抗炎、抗血栓形成、保护血管内皮细胞等功能发挥其抗动脉粥样硬化(As)作用。近年来研究发现HDL含量与其功能不成比例,在As、代谢综合征、慢性炎症、免疫系统疾病患者体内,HDL组分改变如蛋白成分氧化、糖基化等修饰可降低其抗As功能,甚至表现出促炎、促氧化等特性,成为As发生发展的危险因素。 High density lipoprotein( HDL) exhibits antiatherogenic properties for its functions in reverse cholesterol transport,antioxidant,anti-inflammation,anti-thrombosis and protection of vascular endothlial cells. Accumulating evidence has revealed that HDL levels are not positively related with their functions in the patients with atherosclerosis,metabolic syndrome,chronic inflammation or immune system disease. HDL,especially its protein composition,is susceptible to chemical modification including oxidation or glycation and may lose its beneficial role against atherosclerosis,even exhibit pro-atherogenic effect,such as proinflammatory and prooxidation.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2014年第10期1067-1071,共5页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金项目(81370381 81202949) 山东省泰山学者岗专项基金(zd056 zd057)
关键词 高密度脂蛋白 蛋白成分修饰 动脉粥样硬化 功能改变 High Density Lipoprotein Protein Modification Atherosclerosis Functional Changes
  • 相关文献

参考文献29

  • 1Liischer TF, Landmesser U, yon Eckardstein A, et al. High-densi- ty lipoprotein : vascular protective effects, dysfunction, and potential as therapeutic target [ J ]. Circulation Research, 2014, 114 ( 1 ) : 171-182. 被引量:1
  • 2Dansky HM, Bloomfield D, Gibbons P, et al. Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hyper- cholesterolemia or mixed hyperlipidemia [ J ]. Am Heart J, 2011 , 162(4) : 708-716. 被引量:1
  • 3Kontush A, Chapman MJ. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities[ J]. Curt Opin Lip- idol, 2010, 21(4): 312-318. 被引量:1
  • 4Kotosai M, Shimada S, Kanda M, et al. Plasma HDL reduces non- esterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability [ J ]. Lipids, 2013, 48 ( 6 ) : 569 -578. 被引量:1
  • 5Riwanto M, Rohrer L, Roschitzki B, et al. Altered activation of endo- thelial anti- and proapoptntic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein- proteome remodeling[J]. Circulation, 2013, 127(8) : 891-904. 被引量:1
  • 6Brown BE, Nobecourt E, Zeng J, et al. Apolipoprotein AI glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages [ J ]. PLoS One, 2013, 8(5) : 65 430. 被引量:1
  • 7Holzer M, Trieb M, Konya V, et al. Aging affects high-density lipo- protein composition and function[J]. Biochim Biophys Acta, 2013, 1831(9) : 1 442-448. 被引量:1
  • 8Ikkruthi S, Rajappa M, Nandeesha H, et al. Hyperhomocysteine- mia and hyperlipoproteinemia (a) in obese south indian men: an in- dication for increased cardiovascular risk [ J ]. Acta Physial Hung, 2014, 101(1): 13-20. 被引量:1
  • 9Henning MF, Herlax V, Bakas L. Contribution of the C-terminal end of apolipoprotein A1 to neutralization of lipopolysaccharide endo- toxic effect[J]. Innate Immunity, 2011, 17(3) : 327-337. 被引量:1
  • 10Nayyar G, Mishra VK, Handattu SP, et al. Sidedness of interfacial arginine residues and anti-atheregenicity of apolipopretein AI mi- metic peptides[J]. J Lipid Res, 2012, 53(5): 849-858. 被引量:1

二级参考文献16

  • 1Besler C, Heinrich K, Riwanto M, et al. High-density lipoprotein-mediated anti-atherosclerotic and endothelial- protective effects: a potential novel therapeutic target in cardiovascular disease [ J ]. Curt Pharm Des, 2010, 16 ( 13 ) : 1480-1493. 被引量:1
  • 2Rousset X, Shamburek R, Vaisman B, et al. Lecithin Cholesterol Acyltransferase: An Anti- or Pro-atherogenic Factor? [J]. CUlT Atheroscler Rep, 2011, 13 (3) :249- 256. 被引量:1
  • 3Tian L, Long S, Li C, et al. High-density lipoprotein sub- class and particle size in coronary heart disease patients with or without diabetes[J]. Lipids Health Dis, 2012, 11: 54. 被引量:1
  • 4Myerburg R J, Junttila MJ. Sudden cardiac death caused by coronary heart disease[J]. Circulation, 2012, 125 (8) : 1043-1052. 被引量:1
  • 5Rothblat GH, Phillips MC. High-density lipoprotein heter- ogeneity and function in reverse cholesterol transport [ J ]. Curr Opin Lipidol, 2010, 21 (3) :229-238. 被引量:1
  • 6Rye KA, Bursill CA, Lambert G, et al. The metabolism and anti-atherogenic properties of HDL [ J ]. J Lipid Res, 2009, 50(Suppl) :S195-S200. 被引量:1
  • 7Besler C, Ltischer TF, Landmesser U. Molecular mecha- nisms of vascular effects of high-density lipoprotein: alter- ations in cardiovascular disease [ J ]. EMBO Mol Med, 2012, 4(4) :251-268. 被引量:1
  • 8Jia L, Wu X, Fu M, et al. Relationship between apoli- poproteins and the alteration of HDL subclasses in hyper- lipidemic subjects[J]. Clin Chim Acta, 2007, 383 ( 1- 2) :65-72. 被引量:1
  • 9Tian L, Jia L, Fu M, et al. Alterations of high density lipoprotein subclasses in obese subjects [ J ]. Lipids, 2006, 41(8) :789-796. 被引量:1
  • 10HoUeboom AG, Kuivenhoven JA, Vergeer M, et al. Plas- ma levels of lecithin: cholesterol aeyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective ease-control analysis nested in the EPIC-Norfolk population study [ J ]. J Lipid Res, 2010, 51(2) :416-421. 被引量:1

共引文献15

同被引文献132

引证文献10

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部